Production process algorithm model

By monitoring and controlling the gastrodin content in real time in the Tongtian oral liquid production system, the problems of insufficient quality control and easy degradation of gastrodin in the existing technology have been solved, and an efficient and stable production process and product quality have been achieved.

CN123113699APending Publication Date: 2026-11-17TAIJI GRP CHONGQING FULING PHARM FACTORY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510617225.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-14
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The existing quality control methods for Tongtian Oral Liquid are not comprehensive enough, making it impossible to systematically evaluate its intrinsic quality. Furthermore, gastrodin is prone to degradation or denaturation under high-temperature conditions during the production process, resulting in insufficient efficacy and stability of the product.

Method used

The extraction module is equipped with a real-time sample acquisition device and a high-performance liquid chromatography (HPLC) quantitative device. By comparing with standard spectra in the database, the content of gastrodin is monitored and controlled in real time. The production process algorithm model is used for intelligent judgment and control.

Benefits of technology

This improved the stability and purity of gastrodin during extraction, concentration, and filtration, ensuring the pharmacological activity and stability of the final product and achieving efficient quality control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123113699A_ABST
    Figure CN123113699A_ABST
Patent Text Reader

Abstract

This invention relates to a production system for oral liquids and its production process algorithm model, particularly to a system and method for producing oral liquids. The production process algorithm model includes: a) an input submodule for receiving high-performance liquid chromatography (HPLC) chromatogram data from the extraction, concentration, and filtration modules of the oral liquid production system; b) a judgment submodule for analyzing the HPLC chromatogram data received by the input submodule and determining whether the content of gastrodin and / or paeoniflorin and / or gallic acid reaches a preset threshold by comparing the peak area with a preset standard chromatogram in a database; c) an output submodule for issuing operation instructions to subsequent production steps when the judgment submodule determines that the content of gastrodin and / or paeoniflorin and / or gallic acid reaches the preset threshold. This model uses HPLC chromatogram data for real-time monitoring and judgment. The production system of this invention can achieve intelligent control, adjust production parameters in real time, ensure the consistency and stability of product quality, and effectively improve production efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a production system for oral liquids and its production process algorithm model, and in particular to a system and method for producing oral liquids. Technical Background

[0002] Tongtian Oral Liquid is a commonly used traditional Chinese medicine preparation for treating migraines. Its formula originates from the Song Dynasty medical text *Taiping Huimin Heji Jufang*, and consists of 11 herbs including Chuanxiong (Ligusticum striatum), Chishao (Paeonia lactiflora), Tianma (Gastrodia elata), Qianghuo (Notopterygium incisum), Baizhi (Angelica dahurica), Xixin (Asarum heterotropoides), Juhua (Chrysanthemum morifolium), Bohe (Mentha haplocalyx), Fangfeng (Saposhnikovia divaricata), tea leaves, and Gancao (Glycyrrhiza uralensis). It is believed to have the effects of promoting blood circulation, removing blood stasis, dispelling wind, and relieving pain. Modern research indicates that Tongtian Oral Liquid has good efficacy in treating migraines and the recovery period after cerebral infarction. However, existing quality control methods for Tongtian Oral Liquid have certain limitations.

[0003] Currently, the 2020 edition of the Chinese Pharmacopoeia (Part I) only addresses the quality control of paeoniflorin in Tongtian Oral Liquid, which clearly cannot fully reflect its intrinsic quality. Existing literature-reported assay methods also have limitations, such as insufficient selection of indicator components and long assay times. Traditional Chinese medicine compound prescriptions often involve multiple components working synergistically; therefore, quality control of multiple herbs and components can better reflect the overall and systematic nature of their quality. Thus, a more comprehensive and systematic quality evaluation method is urgently needed to control the quality of Tongtian Oral Liquid to ensure its consistency and stability across different batches.

[0004] While some studies have employed HPLC fingerprinting technology to establish quality evaluation systems for traditional Chinese medicine preparations, most lack simultaneous quantitative analysis of multiple active ingredients, making it impossible to systematically evaluate the quality of Tongtian Oral Liquid. Furthermore, methods for determining the content of various active ingredients in Tongtian Oral Liquid have not been fully established, hindering accurate assessment of its intrinsic quality. Tongtian Oral Liquid is a widely used traditional Chinese medicine preparation for treating various diseases, and one of its main components is Gastrodia elata. Gastrodia elata, as a traditional Chinese medicine, possesses various pharmacological effects, including sedation, hypnosis, anticonvulsant, and analgesia. The main active ingredient in Gastrodia elata is gastrodin, whose chemical structure contains multiple hydroxyl groups (-OH) and benzene rings. These structural characteristics make it prone to chemical reactions under high-temperature conditions, leading to degradation or denaturation. The specific reasons are as follows:

[0005] The hydroxyl groups in the gastrodin molecule readily undergo dehydration at high temperatures, forming double bonds or cyclic structures, thus altering its chemical properties. Although the benzene ring exhibits high stability, it can also undergo substitution or addition reactions under high temperature and acid / alkali conditions, leading to changes in its molecular structure.

[0006] High temperatures can cause the chemical bonds within the gastrodin molecule to break, generating smaller molecules and thus losing its pharmacological activity. These characteristics necessitate extreme care during the extraction, concentration, and filtration of gastrodin to ensure its stability and purity. Existing production systems typically lack real-time monitoring and control of gastrodin content in their extraction modules, resulting in inaccurate quality control during production and potentially affecting the efficacy and stability of the final product.

[0007] To overcome the aforementioned problems, this invention proposes an improved oral liquid production system and its production process algorithm model. By incorporating a real-time sample acquisition device and a high-performance liquid chromatography (HPLC) quantitative device in the extraction module, and comparing the results with standard spectra in a database, the content of gastrodin can be monitored and controlled in real time, thereby improving the efficiency and quality of oral liquid production. In this way, this invention can effectively ensure the stability and purity of gastrodin during extraction, concentration, and filtration, ensuring the pharmacological activity and stability of the final product.

[0008] In the production process of Tongtian Oral Liquid, the quality testing of gastrodin is particularly crucial to ensure the integrity of its active ingredients and the stability of its efficacy. Therefore, this invention focuses on solving this problem existing in the prior art, providing a more precise and efficient production method. Summary of the Invention

[0009] One of the objectives of this invention is to provide a production process algorithm model for intelligently determining whether the heating and extraction processes of an intelligent production system should proceed or be terminated.

[0010] To achieve the above objectives, the technical solution of the present invention is as follows:

[0011] 1. Production process algorithm model, including:

[0012] a) Input submodule, used to receive high performance liquid chromatography data from the extraction module, concentration module, and filtration module in the oral liquid production system;

[0013] b) Determination submodule, used to analyze the HPLC chromatogram data received by the input submodule, and determine whether the content of gastrodin and / or paeoniflorin and / or gallic acid reaches the preset threshold by comparing the peak area with the preset standard chromatogram in the database.

[0014] c) Output submodule, used to issue operation instructions to subsequent production steps when the determination submodule determines that the content of gastrodin and / or paeoniflorin and / or gallic acid reaches the preset threshold.

[0015] The following explains the concepts of these modules more clearly.

[0016] a) Input Submodule: The input submodule is the data receiving part of the algorithm model. It is responsible for receiving high-performance liquid chromatography (HPLC) data in real time from multiple modules (extraction module, concentration module, and filtration module) in the oral liquid production system. This data contains information on the chemical composition of the extract, concentrate, and filtrate, which serves as the basis for subsequent analysis and judgment. The input submodule can connect to the output ports of each module to achieve real-time data acquisition and transmission, ensuring the timeliness and accuracy of the data.

[0017] b) Decision Submodule: The main function of the decision submodule is to analyze the HPLC chromatogram data received by the input submodule. The specific steps are as follows: ① Preprocess the collected HPLC chromatogram data, including noise removal and baseline correction, to ensure data clarity and accuracy. ② Calculate the peak area of ​​the processed chromatogram data, extracting the peak area values ​​of each component (gastrodin, paeoniflorin, gallic acid). ③ Compare the calculated peak areas with the peak areas in the preset standard chromatograms in the database. The standard chromatograms have been experimentally determined and verified, representing the content of each component under ideal conditions. ④ Based on the comparison results, determine whether the content of gastrodin, paeoniflorin, and gallic acid reaches the preset threshold. The preset threshold is set according to efficacy and safety requirements to ensure product quality. For example, if the content of gastrodin exceeds the preset threshold, further analysis is conducted to determine whether to continue heating or terminate the extraction process.

[0018] c) Output Submodule: After the judgment submodule completes its analysis and draws a conclusion, the output submodule issues operation instructions to subsequent production steps. Specific execution steps include: ① Generating operation instructions based on the judgment results, such as terminating the extraction process, adjusting the extraction temperature, or continuing filtration. ② Transmitting the generated operation instructions to the corresponding modules, such as the extraction module, concentration module, or filtration module, ensuring that the instructions are promptly communicated and executed. ③ The output submodule can also collect feedback information from each module after executing the instructions, performing real-time monitoring to ensure the stability and quality control of the production process.

[0019] The second objective of this invention is to provide an efficient and stable oral liquid production system for extracting active ingredients from medicinal materials and performing subsequent processing to ultimately prepare high-quality oral liquids.

[0020] To achieve the above objectives, the technical solution of the present invention is as follows:

[0021] A production system incorporating the aforementioned production process algorithm model, the production system being used for oral liquids, includes:

[0022] a) Extraction module, used to dissolve the active ingredients in the medicinal materials into a solvent, and to control the extraction temperature and extraction time through a temperature sensor and a timer;

[0023] b) Concentration module, which receives the extract from the extraction module and concentrates it to provide concentrated liquid for the subsequent filtration module;

[0024] c) Filtration module, used to remove impurities from the concentrate and provide clear filtrate for the preparation module;

[0025] d) A mixing module for mixing the filtered filtrate with other excipients, additives, etc., wherein the mixing module receives the filtrate provided by the filtration module;

[0026] e) The production process algorithm model is used to detect the content of gastrodin and / or paeoniflorin and / or gallic acid, and to analyze and determine it through high performance liquid chromatography data. The determination module is connected to the extraction module, concentration module and filtration module to monitor and control the quality parameters of each module in real time.

[0027] As a preferred embodiment, the oral liquid is Tongtian Oral Liquid; or the oral liquid is composed of the following components by weight: the traditional Chinese medicine composition includes the following components: Chuanxiong, Chishao, Tianma, Qianghuo, Baizhi, Xixin, Juhua, Bohe, Fangfeng, tea, and Gancao.

[0028] As a preferred embodiment, the extraction module in the production system is connected to a high-performance liquid chromatograph for online detection of the content of gastrodin and / or paeoniflorin and / or gallic acid in the extract.

[0029] As a preferred embodiment, in the production system, the temperature sensor in the extraction module is controlled according to the content of gastrodin in the production process algorithm model to control the extraction temperature.

[0030] As a preferred embodiment, in the production system, the gastrodin in the extract sample in the extraction module is converted into high-performance liquid chromatography (HPLC) chromatogram data, which is compared with the peak area in the preset standard chromatogram in the database. When the peak area of ​​the gastrodin in the sample is greater than the peak area in the standard chromatogram, the temperature rise procedure of the extraction is terminated.

[0031] To be more specific, whether the heating process is terminated is determined by the system in this way.

[0032] ① Temperature control in the extraction module. During the extraction process, gastrodin in the extract sample is converted into high-performance liquid chromatography (HPLC) chromatographic data in real time. By connecting an HPLC instrument to the extraction module, the content of gastrodin in the extract can be monitored in real time. The HPLC instrument sends the collected chromatographic data to the input submodule in the production process algorithm model. After receiving this data, the input submodule passes it to the judgment submodule.

[0033] The judgment submodule preprocesses the received HPLC chromatogram data, including noise removal and baseline correction, to ensure data clarity and accuracy. Then, it calculates the peak area of ​​the processed chromatogram data to extract the peak area value of gastrodin. The calculated peak area is compared with the peak area of ​​a preset standard chromatogram in the database to determine whether the gastrodin content reaches a preset threshold.

[0034] If the peak area of ​​gastrodin is less than the threshold in the standard spectrum, the determination submodule will generate a control command to continue the heating process to improve extraction efficiency. If the peak area of ​​gastrodin is greater than or equal to the threshold in the standard spectrum, the determination submodule will generate a command to terminate the extraction process and send it to the output submodule.

[0035] Upon receiving this instruction, the output submodule will terminate the extraction process and stop the heating process by controlling the temperature sensor in the extraction module. This ensures that the content of gastrodin does not exceed the preset threshold, avoids the degradation or denaturation of gastrodin caused by high temperature, and thus improves the stability and purity of gastrodin in the extract.

[0036] ② Comparison of Gastrodin Peak Area in Extract Samples. In the extraction module, gastrodin in the extract sample is converted into high-performance liquid chromatography (HPLC) chromatogram data. A certain amount of extract sample is extracted during the extraction process and immediately sent to the HPLC system for analysis. The HPLC system analyzes the extract sample and generates HPLC chromatogram data. The data includes peak area information for gastrodin, paeoniflorin, and gallic acid in the extract. The HPLC chromatogram data is transmitted in real time to the input submodule of the production process algorithm model via the communication module. The input submodule passes the received data to the judgment submodule, which calculates the peak area and extracts the peak area value of gastrodin. The calculated gastrodin peak area is compared with the peak area in the preset standard chromatogram in the database. The standard chromatogram has been experimentally determined and verified, representing the content of gastrodin under ideal conditions. Based on the comparison results, the judgment submodule generates corresponding operation instructions. If the peak area of ​​gastrodin in the sample is greater than the peak area in the standard chromatogram, the judgment submodule generates an instruction to terminate the extraction process and sends the instruction to the output submodule. After receiving the instruction, the output submodule immediately controls the temperature sensor in the extraction module to stop the heating process and issues operation instructions to subsequent production steps to ensure the efficiency and stability of the extraction process.

[0037] As a preferred embodiment, in the production system, paeoniflorin and / or gallic acid in the extract sample of the extraction module are converted into high-performance liquid chromatography (HPLC) chromatogram data, which are compared with the peak areas in the preset standard chromatograms in the database. When the peak areas of paeoniflorin and / or gallic acid in the sample are greater than the peak areas in the standard chromatograms, the extraction program is terminated.

[0038] Whether the program is terminated can be determined by referring to the rules for terminating the heating program of gastrodin, which will not be elaborated here.

[0039] As a preferred embodiment, in the production system, the concentration module and the filtration module are connected to a turbidimeter to detect the clarity of the concentrate.

[0040] As a preferred embodiment, in the production system, the concentrate also contains no more than 0.5% by weight of unknown impurities, which are conventional byproducts generated during the preparation of the concentrate.

[0041] The third objective of this invention is to provide a highly efficient and stable method for producing oral liquids, which is highly intelligent and effectively reduces the destruction of active ingredients during the production process.

[0042] To achieve the above objectives, the technical solution of the present invention is as follows:

[0043] The method for preparing oral liquid using the aforementioned production system includes the following steps:

[0044] S1: Using a production system including the extraction module, the active ingredients in the medicinal materials are dissolved into a solvent to obtain an extract;

[0045] S2: The extract obtained in step S1 is sent to the concentration module in the same production system for concentration treatment to obtain a concentrated solution;

[0046] S3: The concentrated liquid obtained in step S2 is sent to the filtration module in the same production system for filtration to obtain a clear filtrate.

[0047] S4: The clarified filtrate obtained in step S3 is sent to the blending module in the same production system and mixed with excipients and additives to finally obtain the oral liquid product.

[0048] As a preferred precaution, in the method, the temperature sensor in the extraction module is controlled according to the content of gastrodin in the production process algorithm model to control the extraction temperature. The gastrodin in the extract sample in the extraction module is converted into high-performance liquid chromatography (HPLC) chromatogram data, which is compared with the peak area in a preset standard chromatogram in the database. When the peak area of ​​gastrodin in the sample is greater than the peak area in the standard chromatogram, the temperature increase procedure for extraction is terminated.

[0049] Beneficial effects:

[0050] 1. By real-time monitoring and control of the content of effective components in each step of the extraction, concentration and filtration modules, especially the content of gastrodin, paeoniflorin and gallic acid, the production process algorithm model of the present invention can effectively avoid the degradation of gastrodin under high temperature conditions, thereby significantly improving the stability and purity of gastrodin in the extract and ensuring the pharmacological activity of the final product.

[0051] 2. By using high-performance liquid chromatography (HPLC) data for real-time monitoring and judgment, the production system of this invention can achieve intelligent control, adjust production parameters in real time, ensure the consistency and stability of product quality, and effectively improve production efficiency.

[0052] 3. By connecting a turbidimeter to test the clarity of the concentrate, the clarity quality of the concentrate is ensured, the impact of impurities in the production process on the quality of the final product is reduced, and the high quality of the oral liquid is further guaranteed.

[0053] 4. The production system and method of the present invention reduce the risk of damage to the effective components in the production process by optimizing temperature control during the extraction and concentration process, thereby ensuring the stability and efficacy of the final product.

[0054] 5. The production method provided by this invention is not only applicable to the production of Tongtian oral liquid, but can also be applied to the production of other traditional Chinese medicine oral liquids. It has strong versatility and adaptability, and provides strong technical support for the standardization and efficient production of traditional Chinese medicine preparations.

[0055] Instruction manual illustrations

[0056] Figure 1 This is a flowchart illustrating an embodiment of this application.

[0057] Figure 2 This is one of the standard spectra preset in the database. The two circles from left to right are the labeled characteristic peaks of gallic acid and gastrodin, respectively. Detailed Implementation

[0058] Example 1

[0059] This embodiment provides a highly efficient oral liquid production system for extracting active ingredients from medicinal materials and performing subsequent processing to ultimately prepare high-quality Tongtian oral liquid. The system prepares Tongtian oral liquid according to a prescribed process within the following modules.

[0060] S101: The extraction module 10 prepares the extract. This is used to dissolve the active ingredients from the medicinal materials into the solvent. The extraction temperature is controlled by a temperature sensor 101, and the extraction time is controlled by a timer 102. A high-performance liquid chromatograph 103 is connected to the extraction module for online detection of the contents of gastrodin, paeoniflorin, and gallic acid in the extract. The gastrodin, paeoniflorin, and gallic acid in the extract sample are converted into high-performance liquid chromatographic data 104, compared with the peak areas in preset standard chromatograms in the database, and the extraction temperature is controlled in real time based on the comparison results to ensure that the gastrodin content reaches the preset threshold.

[0061] S102: Controls the heating program of the extract and the extraction program of S101 under the production process algorithm model 50. This model includes an input submodule 501, a judgment submodule 502, and an output submodule 503. The input submodule receives the high-performance liquid chromatography (HPLC) chromatogram data from the extraction module, and the judgment submodule analyzes the data and compares it with preset standard chromatograms in the database. Figure 2 The peak areas in the samples are compared to determine whether the content of gastrodin has reached a preset threshold. When the content reaches the preset threshold, the output submodule issues operation instructions to subsequent production steps, such as controlling the temperature sensor in the extraction module or terminating the extraction process. Through the coordinated work of the above modules, the production system of this embodiment can monitor and control the content of gastrodin, paeoniflorin, and gallic acid in real time, ensuring the stable quality and reliable efficacy of Tongtian Oral Liquid.

[0062] S103: Concentrate preparation is performed in concentration module 20. The concentration module receives the extract from the extraction module and concentrates it to provide concentrate for the subsequent filtration module. Furthermore, this module can be additionally connected to a turbidimeter 201 to detect the clarity of the concentrate, ensuring its quality.

[0063] S104: Filtration is performed in the filtration module 30 to obtain filtrate. The filtration module is used to remove impurities from the concentrate, providing a clear filtrate for the preparation module. A turbidimeter 301 is also connected to this module to monitor the impurities in the concentrate in real time.

[0064] S105: Tongtian Oral Liquid is finally obtained in the blending module 40. The blending module is used to mix and blend the filtered liquid with other excipients, additives, etc. This module receives the filtrate provided by the filtration module, mixes and blends it, and finally obtains the finished oral liquid product. Tongtian Oral Liquid is mainly composed of the following components: Chuanxiong, Chishao, Tianma, Qianghuo, Baizhi, Xixin, Juhua, Bohe, Fangfeng, tea, and Gancao.

[0065] Comparative Examples

[0066] To verify the necessity and effectiveness of the algorithm model of the present invention, this embodiment provides a comparative example in which, during the extraction process, when the peak area of ​​gastrodin in the sample is greater than the peak area in the standard spectrum, the temperature rise procedure of the extraction is not terminated.

[0067] Using the same extraction module as in this invention, the active ingredients in traditional Chinese medicine components (such as Chuanxiong, Chishao, and Tianma) are dissolved into a solvent. However, in the experiment, the production process algorithm model of this invention was not used to monitor and control the content of gastrodin in real time, therefore the temperature rise procedure of the extraction was not terminated.

[0068] During the extraction process, the contents of gastrodin and paeoniflorin in the extract were detected online using high-performance liquid chromatography (HPLC). Experimental data showed that as the extraction temperature continued to rise, the peak area of ​​gastrodin exceeded the threshold in the standard chromatogram, but the temperature increase program for extraction was not terminated.

[0069] After extraction, further analysis of the gastrodin in the sample revealed changes in its molecular structure. Specifically, the hydroxyl groups in gastrodin underwent dehydration at high temperatures, forming double bonds or cyclic structures, leading to alterations in the chemical properties of gastrodin. Furthermore, the benzene ring also underwent substitution or addition reactions under high-temperature conditions, further affecting the molecular structure of gastrodin.

[0070] Example 2

[0071] To verify the effectiveness and accuracy of the oral liquid production system of the present invention, we conducted the following embodiments. The production system in this embodiment includes an extraction module, a concentration module, a filtration module, and a blending module, and each module is connected to a production process algorithm model.

[0072] I. Implementation Steps

[0073] 1. Extraction module operation

[0074] Add the medicinal materials (including Chuanxiong, Chishao, Tianma, Qianghuo, Baizhi, Xixin, Juhua, Bohe, Fangfeng, tea, and Gancao, etc.) to the extraction tank according to the weight proportions, and add an appropriate amount of solvent (such as water or ethanol).

[0075] The extraction temperature is controlled by a temperature sensor, and the extraction time is controlled by a timer. During the extraction process, the extract sample is converted into high-performance liquid chromatography (HPLC) chromatographic data in real time.

[0076] The extraction temperature is controlled based on the gastrodin content in the production process algorithm model. When the peak area of ​​gastrodin in the extract sample is smaller than the peak area in the preset standard spectrum in the database, the temperature increase program continues. When the peak areas of paeoniflorin and gallic acid equal the standard spectrum, the extraction program is terminated to ensure maximum extraction efficiency and prevent gastrodin decomposition.

[0077] 2. Concentration Module Operation

[0078] The extract from the extraction module is fed into the concentration module for concentration to obtain a concentrated solution. The clarity of the concentrated solution is monitored in real time by a turbidimeter to ensure that the clarity meets the requirements.

[0079] 3. Filtering module operation

[0080] The concentrate is fed into a filtration module to remove impurities, ensuring a clear filtrate. The clear filtrate is then fed into a blending module.

[0081] 4. Allocation Module Operation

[0082] The clarified filtrate is mixed with excipients and additives to obtain the final oral liquid product. After preparation, the oral liquid undergoes quality testing to ensure that the content of each component meets the preset requirements.

[0083] II. Implementation Results

[0084] Through the above embodiments, we have verified that the oral liquid production system of the present invention can efficiently and accurately control the extraction process, ensuring that the contents of gastrodin, paeoniflorin and gallic acid reach the optimal state.

[0085] The peak area of ​​gastrodin remained consistently below the threshold of the standard chromatogram, preventing degradation or denaturation caused by high temperatures. When the peak areas of paeoniflorin and gallic acid reached the levels of the standard chromatogram, the extraction process automatically terminated, ensuring maximum extraction efficiency while also ensuring the full extraction of other components. This invention's oral liquid production system effectively improves the efficiency and quality of oral liquid production by real-time monitoring and control of the content of gastrodin, paeoniflorin, and gallic acid in the extract. Experimental results show that this system can ensure the pharmacological activity and stability of the final product, and is particularly suitable for the production of traditional Chinese medicine preparations such as Tongtian Oral Liquid.

[0086] Comparative Example 2

[0087] To further verify the effectiveness of the algorithm model of this invention, we conducted the following comparative examples. In these examples, the production process was not carried out according to the rules of terminating the heating and extraction process based on the contents of gastrodin, paeoniflorin, and gallic acid, which resulted in a decrease in the extraction rate and an increase in the rate of chemical structure destruction of gastrodin.

[0088] I. Comparison of Implementation Steps

[0089] 1. Extraction module operation

[0090] Add the medicinal materials (including Chuanxiong, Chishao, Tianma, Qianghuo, Baizhi, Xixin, Juhua, Bohe, Fangfeng, tea, and Gancao, etc.) to the extraction tank according to the weight proportions, and add an appropriate amount of solvent (such as water or ethanol).

[0091] The extraction temperature is controlled by a temperature sensor, and the extraction time is controlled by a timer. During the extraction process, the extract sample is converted into high-performance liquid chromatography (HPLC) chromatographic data in real time.

[0092] However, in this embodiment, the production process algorithm model of the present invention is not used to monitor and control the content of gastrodin, paeoniflorin, and gallic acid in real time. The temperature rise and extraction procedures are carried out according to a predetermined time or temperature, regardless of the content of these active ingredients.

[0093] 2. Concentration Module Operation

[0094] The extract from the extraction module is fed into the concentration module for concentration to obtain a concentrated solution. The clarity of the concentrated solution is monitored in real time by a turbidimeter to ensure that the clarity meets the requirements.

[0095] 3. Filtering module operation

[0096] The concentrate is fed into a filtration module to remove impurities, ensuring a clear filtrate. The clear filtrate is then fed into a blending module.

[0097] 4. Module Operation

[0098] The clarified filtrate is mixed with excipients and additives to obtain the final oral liquid product. After preparation, the oral liquid undergoes quality testing to ensure that the content of each component meets the preset requirements.

[0099] II. Comparison of Implementation Results

[0100] Because the contents of gastrodin, paeoniflorin, and gallic acid were not monitored and controlled in real time, the extraction temperature continued to rise until the predetermined temperature or time was reached. This led to the degradation or denaturation of the active ingredients during extraction, resulting in a decrease in the extraction rate. The lack of real-time monitoring of gastrodin content to control the extraction temperature caused changes in the molecular structure of gastrodin at high temperatures. Specifically, the hydroxyl groups in gastrodin underwent dehydration reactions at high temperatures, forming double bonds or cyclic structures, leading to changes in the chemical properties of gastrodin. Furthermore, the benzene ring also underwent substitution or addition reactions under high-temperature conditions, further affecting the molecular structure of gastrodin.

[0101] By comparing Example 2, we clearly see that without using the production process algorithm model of this invention, the effective components undergo degradation or denaturation during the extraction process, ultimately leading to a decrease in extraction rate and an increase in the destruction rate of the gastrodin's chemical structure. This further verifies the importance and effectiveness of the algorithm model of this invention in controlling the extraction process.

Claims

1. A production process algorithm model, characterized in that, include: a) Input submodule, used to receive high performance liquid chromatography data from the extraction module, concentration module, and filtration module in the oral liquid production system; b) Determination submodule, used to analyze the HPLC chromatogram data received by the input submodule, and determine whether the content of gastrodin and / or paeoniflorin and / or gallic acid reaches the preset threshold by comparing the peak area with the preset standard chromatogram in the database. c) Output submodule, used to issue operation instructions to subsequent production steps when the determination submodule determines that the content of gastrodin and / or paeoniflorin and / or gallic acid reaches the preset threshold.

2. A production system comprising the production process algorithm model of claim 1, characterized in that, The production system is used for oral liquids and includes: a) Extraction module, used to dissolve the active ingredients in the medicinal materials into a solvent, and to control the extraction temperature and extraction time through a temperature sensor and a timer; b) Concentration module, which receives the extract from the extraction module and concentrates it to provide concentrated liquid for the subsequent filtration module; c) Filtration module, used to remove impurities from the concentrate and provide clear filtrate for the preparation module; d) A mixing module for mixing the filtered filtrate with other excipients, additives, etc., wherein the mixing module receives the filtrate provided by the filtration module; e) The production process algorithm model is used to detect the content of gastrodin and / or paeoniflorin and / or gallic acid, and to analyze and determine it through high performance liquid chromatography data. The determination module is connected to the extraction module, concentration module and filtration module to monitor and control the quality parameters of each module in real time.

3. The production system according to claim 2, characterized in that, The oral liquid is Tongtian Oral Liquid; or the oral liquid is composed of the following components by weight: the traditional Chinese medicine composition includes the following components: Chuanxiong, Chishao, Tianma, Qianghuo, Baizhi, Xixin, Juhua, Bohe, Fangfeng, tea, and Gancao.

4. The production system according to claim 2, characterized in that, The extraction module is connected to a high-performance liquid chromatograph for online detection of the content of gastrodin and / or paeoniflorin and / or gallic acid in the extract.

5. The production system according to claim 2, characterized in that, The extraction temperature is controlled by the temperature sensor in the extraction module based on the content of gastrodin in the production process algorithm model.

6. The production system according to claim 4, characterized in that, In the extraction module, the gastrodin in the extract sample is converted into high-performance liquid chromatography (HPLC) chromatogram data, which is compared with the peak area in the preset standard chromatogram in the database. When the peak area of ​​gastrodin in the sample is greater than the peak area in the standard chromatogram, the temperature increase program of the extraction is terminated.

7. The production system according to claim 6, characterized in that, In the extraction module, paeoniflorin and / or gallic acid in the extract sample are converted into high-performance liquid chromatography (HPLC) chromatogram data, which are compared with the peak areas in the preset standard chromatograms in the database. When the peak areas of paeoniflorin and / or gallic acid in the sample are greater than the peak areas in the standard chromatograms, the extraction program is terminated.

8. The production system according to claim 1, characterized in that, The concentration module and filtration module are connected to a turbidimeter to detect the clarity of the concentrate.

9. The production system according to claim 6, characterized in that, The concentrate also contains no more than 0.5% by weight of unknown impurities, which are conventional byproducts generated during the preparation of the concentrate.

10. A method for preparing oral liquid using the production system according to any one of claims 2-10, characterized in that, Includes the following steps: S1: Using a production system including the extraction module, the active ingredients in the medicinal materials are dissolved into a solvent to obtain an extract; S2: The extract obtained in step S1 is sent to the concentration module in the same production system for concentration treatment to obtain a concentrated solution; S3: The concentrated liquid obtained in step S2 is sent to the filtration module in the same production system for filtration to obtain a clear filtrate. S4: The clarified filtrate obtained in step S3 is sent to the blending module in the same production system and mixed with excipients and additives to finally obtain the oral liquid product.